Markwell Clarizio LLP

health canada

Health Canada and FDA Move Towards A Request for Information Sharing (RIS) Program for Generic Drugs

On December 1, 2025, Health Canada announced the creation of a joint program with the U.S. Food and Drug Administration (FDA) to support the establishment of a Request for Information Sharing (RIS) program for generic drugs. Specific commitments and timelines under this program have not yet been released. The RIS program is intended to facilitate […]

Health Canada and FDA Move Towards A Request for Information Sharing (RIS) Program for Generic Drugs Read More »

Announcement of a new Canadian Drug Agency by the Government of Canada

On December 18, 2023, the Government of Canada announced the creation of the Canadian Drug Agency (“CDA”) built from CADTH in partnership with provinces and territories. The implementation of CDA is supported by an investment of $89.5 million over 5 years.   The creation of the CDA has been in the works for many years.

Announcement of a new Canadian Drug Agency by the Government of Canada Read More »